Provided herein are novel compounds as PKC-theta inhibitors, pharmaceutical compositions, use of such compounds in treating autoimmune or inflammatory diseases, and processes for preparing such compounds.
No takes yet. Share an insight, caveat, or question.
Ram W. Sabnis (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: